EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Altered DNA Methyltransferase Expression in Pulmonary Large‐Cell Neuroendocrine Carcinoma: Pilot Experimental Data Targeted DNMT1 , DNMT3A , and DNMT3B

Adam Put iD, Katerina Smesny Trtkova iD, Marcel Mittak iD, Petra Herentinova, Jana Vaculova iD, Radoslava Cernekova, Jozef Skarda iD

Cancer Reports · 2026-03 · 9 (3)

DOI: 10.1002/cnr2.70513 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, online erschienen am 19.03.2026. Verfasst von Adam Put und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Molecular Pathology and Medical Genetics, Faculty of Medicine, University of Ostrava, Ostrava, Czechia. Hauptthemen laut MEDLINE: DNA (Cytosine-5-)-Methyltransferase 1, Lung Neoplasms, DNA (Cytosine-5-)-Methyltransferases, Carcinoma, Large Cell. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union under the LERCO, Palacký Univerzity Olomouc grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Large cell neuroendocrine carcinoma (LCNEC) is a subtype of non‐small‐cell lung carcinoma with poorly understood methylation characteristics, including the activity of DNA methyltransferases. Despite the pivotal role of DNA methyltransferases in epigenetic regulation, their expression profile in LCNEC remains unexplored. This study represents the first effort to evaluate the expression of DNMT1 , DNMT3A , and DNMT3B genes in patients with LCNEC. Materials and Methods We performed quantitative expression analyses of DNMT1, DNMT3A, and DNMT3B on formalin‐fixed, paraffin‐embedded tissue samples obtained from LCNEC patients. Normal lung tissues ( n = 4) from healthy patients served as controls to determine differential expression levels.

Results

The analysis revealed upregulation of both DNMT1 and DNMT3A compared to control normal lung tissue. In addition, normalized expression values of DNMT3B were reduced compared to the analyzed DNMT1 and DNMT3A.

Conclusion

In this exploratory pilot of 18 LCNEC cases, DNMT1 and DNMT3A transcripts were frequently higher relative to a normal‐lung calibrator, while DNMT3B results were inconclusive due to technical limitations and small sample size. These descriptive findings warrant validation in larger, isoform‐resolved cohorts before clinical inference. Future research should prioritize investigating these DNA methyltransferases to explore their therapeutic implications. Moreover, future research should also aim to detect and characterize individual DNMT3B isoforms in LCNEC patients to further elucidate their specific contributions to the pathology of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA (Cytosine-5-)-Methyltransferase 1Lung NeoplasmsDNA (Cytosine-5-)-MethyltransferasesCarcinoma, Large CellCarcinoma, NeuroendocrineHumansDNA Methyltransferase 3ADNA Methyltransferase 3BFemalePilot ProjectsMaleMiddle AgedAgedGene Expression Regulation, NeoplasticDNA MethylationAdultCase-Control Studies

Stichwörter der Autor:innen

DNA methyltransferasesDNMT3B isoformslarge cell neuroendocrine carcinomas

Substanzen

DNA Methyltransferase 3ADNA Methyltransferase 3BDNA (Cytosine-5-)-Methyltransferase 1DNMT3A protein, humanDNMT1 protein, humanDNA (Cytosine-5-)-Methyltransferases

Autor:innen und Institutionen

  • Department of Clinical and Molecular Pathology and Medical Genetics, Faculty of Medicine, University of Ostrava, Ostrava, Czechia.
  • Department of Clinical and Molecular Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czechia.
  • Department of Clinical and Molecular Pathology, Faculty of Medicine, Palacký University Olomouc, Olomouc, Czechia.

ORCID-Profile: Adam Put, Katerina Smesny Trtkova, Marcel Mittak, Jana Vaculova, Jozef Skarda

Förderung

  • European Union under the LERCO
  • Palacký Univerzity Olomouc grant

Zitieren

APA

Put, A., Trtkova, K. S., Mittak, M., Herentinova, P., Vaculova, J., Cernekova, R., & Skarda, J. (2026). Altered DNA Methyltransferase Expression in Pulmonary Large‐Cell Neuroendocrine Carcinoma: Pilot Experimental Data Targeted DNMT1 , DNMT3A , and DNMT3B. Cancer Reports, 9(3). https://doi.org/10.1002/cnr2.70513

Vancouver

Put A, Trtkova KS, Mittak M, Herentinova P, Vaculova J, Cernekova R, et al. Altered DNA Methyltransferase Expression in Pulmonary Large‐Cell Neuroendocrine Carcinoma: Pilot Experimental Data Targeted DNMT1 , DNMT3A , and DNMT3B. Cancer Reports. 2026;9(3). doi:10.1002/cnr2.70513

BibTeX
@article{Put2026,
  author = {Put, Adam and Trtkova, Katerina Smesny and Mittak, Marcel and Herentinova, Petra and Vaculova, Jana and Cernekova, Radoslava and Skarda, Jozef},
  title = {Altered DNA Methyltransferase Expression in Pulmonary Large‐Cell Neuroendocrine Carcinoma: Pilot Experimental Data Targeted DNMT1 , DNMT3A , and DNMT3B},
  journal = {Cancer Reports},
  year = {2026},
  volume = {9},
  number = {3},
  doi = {10.1002/cnr2.70513}
}
Kostenlos starten →